Furthermore, the reduced level of HIF reduces the expression of the GLUT-1 transporter and consequently decreases glucose uptake into tumour cells, lactate production, Akt and mTOR signalling, and cell viability, depending on the dose and time. This evidence concerns the gene AKT1 and neoplasm.